课题基金 / 基金详情

Analysis of signal transduction among cells in the pathogenesis of heart failure and its application for the diagnosis and treatment

Analysis of signal transduction among cells in the pathogenesis of heart failure and its application for the diagnosis and treatment
心力衰竭发病机制中细胞间信号转导分析及其在诊治中的应用
批准号:
08407018
负责人:
SASAYAMA Shigetake
金额:
$24.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

SASAYAMA Shigetake的其他基金

相似基金

相关文献

中文摘要
翻译
细胞因子在心力衰竭的发病机制和病理生理机制中的作用日益受到重视。在我们的脑心肌炎病毒性心肌炎所致充血性心力衰竭小鼠模型中,白介素1β、白介素2、肿瘤坏死因子和干扰素的信使RNA的表达在急性期增加,但在病毒接种后持续很长时间。我们还研究了Dahl盐敏感(DS)大鼠左室肥厚和随后出现心力衰竭迹象的细胞因子的表达。用定量逆转录聚合酶链式反应检测DS大鼠左室IL-1βmRNA含量,发现DS大鼠左室肥厚时IL-1βm RNA含量增加,CHF时较同龄Dahl耐盐(DR)大鼠进一步升高。在DS大鼠心肌梗死后1周,IL-1β、IL-6和TNF-α基因表达达高峰,随后在梗死区迅速下降。相反,在梗死后20周,这些细胞因子的基因表达水平在非梗死区仍显著高于梗死区。此外,这些细胞因子在非梗死区的水平与慢性期测量的左心室舒张末内径相关。随着我们对细胞因子在心力衰竭中的病理生理学和致病作用有更多的了解,应该有可能设计出更好和更有针对性的药物。
英文摘要
Cytokines are being increasingly recognized as important factors in the pathogenesis and pathophysiology of heart failure. Elevated levels of circulating cytokines have been reported in patients with heart failure, and various cytokines have been shown to depress myocardial contractility in vitro and in vivo.In our murine model of congestive heart failure resulting from encephalomyocarditis virus myocarditis, expression of messenger RNAs of interleukin (IL)-1beta, IL-2, TNF-alpha and interferon gamma increased in the acute stage, but persisted long after virus inoculation.We also investigated cytokine expression in Dahl salt-sensitive (DS) rats that developed hypertrophy of the left ventricle and subsequently showed signs of heart failure, and in a rat model of ischemic heart failure. The IL-1beta mRNA content of the LV of DS rats determined by quantitatibe reverse-transcriptase polymerase chain reaction was increased when LV hypertrophy developed, and further increased at the CHF stage compared with that of age-matched Dahl salt-resistant (DR) rats. In DS rats, the number of interstitial macrophages increased, and most of the IL-1beta immunoreactivity was localized in those macrophages throughout the LV.In rat model of myocardial infarction, IL-1beta, IL-6 and TNF-alpha gene expressions peaked at 1 week after infarction and decreased rapidly thereafter in the infarcted region. In contrast, at 20 weeks after infarction, the gene expression levels of these cytokines remained significantly higher in the noninfarcted than in the infarcted zone. Furthermore, the levels of these cytokines in the noninfarcted region correlated with the LV end-diastolic diameter measured in the chronic stage.As we learn more about the pathophysiological and pathogenetic role of cytokines in heart failure, it should be possible to design better and more targeted pharmacological agents.
期刊论文(112)
专著(0)
科研奖励(0)
会议论文
Furukawa Y,et al.: "Immunomodulation by an adenylate cyclase activator,NKH477,in vivo and in vitro" Clin Immunol Immunopathol. 79. 25‐35 (1996)
Furukawa Y 等人:“体内和体外通过腺苷酸环化酶激活剂 NKH477 进行免疫调节”,《临床免疫病理学》79. 25-35 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsumori A,et al.: "Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy" Biochem Biophys Res Commun. 222. 678‐682 (1996)
Matsumori A 等人:“肥厚型心肌病患者心脏中丙型肝炎病毒 RNA 的检测”Biochem Biophys Res Commun。222. 678-682 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shioi T,et al.: "Protective role of Interleukin-12 in viral myocarditis." J Mol Cell Cardiol. 29. 2327-2334 (1997)
Shioi T 等人:“Interleukin-12 在病毒性心肌炎中的保护作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hasegawa K, et al.: "Endothelin-1 and its receptor in hypertrophic cardiomyopathy." Hypertension. 27. 254-264 (1996)
Hasekawa K 等人:“肥厚型心肌病中的内皮素-1 及其受体”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
79
    Analysis of the role of p38 MAP kinase in heart failure using transgenic mice
    • 批准号:
      11307012
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $24.0万
    • 财政年份:
      1999
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    Analysis of novel proteins produced by vascular tissues and their clinical application
    • 批准号:
      11557052
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.19万
    • 财政年份:
      1999
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    DEVELOPMENT OF GENE THERAPY FOR CARDIOVASCULAR DISEASES
    • 批准号:
      08044273
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $10.11万
    • 财政年份:
      1996
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    Cellular interaction in pathogenesis of cardiac dysfuction
    • 批准号:
      07044253
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $5.31万
    • 财政年份:
      1995
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    国内基金
    海外基金
    KCTD10对2型免疫反应(Th2)的调控研究
    • 批准号:
      2020JJ4441
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      任凯群
    • 依托单位:
    IL-6受体泛素化调控机制
    • 批准号:
      32070775
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      李姝
    • 依托单位:
    乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
    • 批准号:
      31970735
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      江静
    • 依托单位:
    USP13调控IL-18诱导的NF-κB活化的分子机制研究
    • 批准号:
      31900556
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2019
    • 负责人:
      林恒
    • 依托单位: